AMGN Amgen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMGN

Price (delayed)

$345.92

Market cap

$186.7B

P/E Ratio

23.89

Dividend/share

$9.8

EPS

$14.48

Enterprise value

$231.98B

?
Relative Growth: Rel. Growth: 74
Relative Strength: Rel. Strength: 51
Relative Valuation: Rel. Valuation: 57
Relative Profitability: Rel. Profitability: 95

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980. ...

Highlights
Amgen's equity has increased by 48% YoY and by 6% from the previous quarter
The net income has grown by 31% YoY
The P/E is 7% below the 5-year quarterly average of 25.7 but 4% above the last 4 quarters average of 22.9
The debt rose by 5% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.amgen.com/
Peers: BMY PFE GILD ABBV

Key stats

What are the main financial stats of AMGN

AMGN stock price

How has the Amgen stock price performed over time
Intraday
0.35%
1 week
-0.55%
1 month
1.95%
1 year
26.97%
YTD
5.69%
QTD
-1.69%

Financial performance

How have Amgen's revenue and profit performed over time
Revenue
$37.22B
Gross profit
$25.41B
Operating income
$10.57B
Net income
$7.8B
Gross margin
68.3%
Net margin
21%
AMGN's operating income is up by 42% year-on-year and by 16% since the previous quarter
The net income has grown by 31% YoY
The company's operating margin rose by 30% YoY and by 15% QoQ
The net margin rose by 21% year-on-year

Price vs fundamentals

How does AMGN's price correlate with its fundamentals

Growth

What is Amgen's growth rate over time

Valuation

What is Amgen stock price valuation
AMGN P/E details
P/E
23.89
P/B
20.29
P/S
5.02
EV/EBIT
19.7
EV/EBITDA
13.91
EV/Sales
6.23
AMGN's EPS is up by 31% year-on-year
The P/E is 7% below the 5-year quarterly average of 25.7 but 4% above the last 4 quarters average of 22.9
Amgen's equity has increased by 48% YoY and by 6% from the previous quarter
The stock's price to book (P/B) is 35% less than its 5-year quarterly average of 30.9 but 4.8% more than its last 4 quarters average of 19.3
The revenue has grown by 9% year-on-year
The P/S is 9% more than the last 4 quarters average of 4.6 and 2% more than the 5-year quarterly average of 4.9

Efficiency

How efficient is Amgen business performance
AMGN's return on assets is up by 32% year-on-year
The ROIC has grown by 22% YoY
AMGN's return on sales is up by 11% year-on-year
The ROE has contracted by 8% from the previous quarter and by 3.8% YoY

Dividends

What is AMGN's dividend history
Dividend details
DPS
$9.8
Dividend yield
2.83%
Payout ratio
67.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Amgen financials performed over time
Amgen's total assets is 11% more than its total liabilities
AMGN's quick ratio is up by 16% since the previous quarter and by 15% year-on-year
Amgen's current ratio has increased by 11% from the previous quarter and by 8% YoY
Amgen's equity has increased by 48% YoY and by 6% from the previous quarter
AMGN's debt to equity is down by 32% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.